Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Mark L Chiu

7PUBLICATIONS

2CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsBiomaterialsHaematologyAllergy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 07, 2026

A novel insulin-like growth factor II-based masking domain for conditional activation of therapeutic antibodies.

|Mar 24, 2026

Effect of ADCC-enhancing mutations on N-glycan profiles of human IgG1 antibodies.

Lu Han, Hao Jiang, Mark L Chiu

|Nov 20, 2025

Engineering tandem VHHs to target different epitopes to enhance antibody-dependent cell-mediated cytotoxicity.

Yuqiang Xu, Hao Jiang, Limin Chen

|Nov 13, 2025

Targeted Hyaluronan Degradation Enhanced Tumor Growth Inhibition in Gastrointestinal Cancer Models.

Fulai Zhou, Guangmao Mu, Honglei Bi

|Aug 22, 2025

Guidelines in the Preparation of Fully Synthetic, Human Single-Domain Antibody Phage Display Libraries.

Mark A Tornetta, Brian P Whitaker, Olivia M Cantwell

|Aug 14, 2024

Phase 1 Safety and Pharmacokinetics Study of TAVO101, an Anti-Human Thymic Stromal Lymphopoietin Antibody for the Treatment of Allergic Inflammatory Conditions.

Chao Han, Isa Fung, Di Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Mark A Tornetta

1 joint publications

Di Zhang

Frequent Collaborators

1 joint publications

Mark A Tornetta

1 joint publications

Di Zhang